EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hesperidin enhances intestinal barrier function in Caco‐2 cell monolayers via AMPK ‐mediated tight junction‐related proteins

Ha-Young Park iD, Jin-Hee Yu iD

FEBS Open Bio · 2023

DOI: 10.1002/2211-5463.13564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Ha-Young Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Korea. Hauptthemen laut MEDLINE: Hesperidin, Flavanones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intestinal epithelium is a single‐cell layer on the mucosal surface that absorbs food‐derived nutrients and functions as a barrier that protects mucosal integrity. Hesperidin (hesperetin‐7‐rhamnoglucoside) is a flavanone glycoside composed of the flavanone hesperetin and the disaccharide rutinose, which has various physiological benefits, including antioxidative, anti‐inflammatory, and antiallergic effects. Here, we used human intestinal Caco‐2 cell monolayers to examine the effect of hesperidin on intestinal barrier function. Hesperidin‐treated Caco‐2 cell monolayers displayed enhanced intestinal barrier integrity, as indicated by an increase in transepithelial electrical resistance (TEER) and a decreased apparent permeability (P app ) for fluorescein. Hesperidin elevated the mRNA and protein levels of occludin, MarvelD3, JAM‐1, claudin‐1, and claudin‐4, which are encoded by tight junction (TJ)‐related genes. Moreover, hesperidin significantly increased the phosphorylation of AMP‐activated protein kinase (AMPK), indicating improved intestinal barrier function. Thus, our results suggest that hesperidin enhances intestinal barrier function by increasing the expression of TJ‐related occludin, MarvelD3, JAM‐1, and claudin‐1 via AMPK activation in human intestinal Caco‐2 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HesperidinFlavanonesHumansCaco-2 CellsTight Junction ProteinsOccludinAMP-Activated Protein KinasesTight JunctionsClaudin-1

Stichwörter der Autor:innen

AMP-activated protein kinaseCaco-2 cellshesperidinparacellular transporttight junction

Substanzen

Tight Junction ProteinsOccludinAMP-Activated Protein KinasesHesperidinClaudin-1Flavanones

Autor:innen und Institutionen

  • Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Korea.

ORCID-Profile: Ha-Young Park, Jin-Hee Yu

Förderung

  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea

Zitieren

APA

Park, H. Y., & Yu, J. H. (2023). Hesperidin enhances intestinal barrier function in Caco‐2 cell monolayers via AMPK ‐mediated tight junction‐related proteins. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13564

Vancouver

Park HY, Yu JH. Hesperidin enhances intestinal barrier function in Caco‐2 cell monolayers via AMPK ‐mediated tight junction‐related proteins. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13564

BibTeX
@article{Park2023,
  author = {Park, Ha-Young and Yu, Jin-Hee},
  title = {Hesperidin enhances intestinal barrier function in Caco‐2 cell monolayers via AMPK ‐mediated tight junction‐related proteins},
  journal = {FEBS Open Bio},
  year = {2023},
  doi = {10.1002/2211-5463.13564}
}
Kostenlos starten →